Lam, Du

Everolimus in patients with advanced, progressive pancreatic neuroendocrine tumors: Overall survival results from the phase III RADIANT-3 study after adjusting for crossover bias.

Pavel, Marianne, Lam, Du, Kunz, Tiffany, Brandt, Ulrike , Capdevila, Jaume , Tomassetti, Paola, Hobday, Timothy J. , Pommier, Rodney F. , Lombard‐Bohas, Catherine , Cutsem, Eric Van , Vries, Elisabeth G.E. de , Yao, James C.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4091-4091

10.1200/jco.2015.33.15_suppl.4091